Rehab Muhammad Abd Elkareem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rehab Muhammad Abd Elkareem has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Yasmen Awadalh Mohamed
Department of Pediatrics, Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt
4 shared publications - Heba Mostafa Ahmed
Department of Pediatrics, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
3 shared publications - Osama Ezzat Botrous
Department of Pediatrics, Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt
2 shared publications - Abdelrahman Gamal Abdelaziz Mohamed
Internal Medicine Department, Faculty of Medicine, Beni-Suef University, Egypt
1 shared publication - Ahmed Hamdy Zabady
Faculty of Science, Damanhour University, Damanhour 22514, Egypt
1 shared publication - Ahmed Reda Sayed
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Beni-Suef University, Beni Suef, Egypt
1 shared publication
Latest Publications
- Open Access
- 12 May 2026
- Published by MDPI AG in BioMedInformatics
- Vol. 6 (3) , 28
Clinical Outcomes of Daratumumab-Containing Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: This study examines the clinical efficacy of daratumumab when combined with other therapeutic agents in patients with multiple myeloma, with a focus on key outcomes including overall response, progression-free survival (PFS), and stringent complete response (sCR). Methods: A systematic literature search was conducted using PubMed, Web of Science, Scopus, and the Cochrane Library. Statistical analyses were performed with R software (version 4.2.2). Between-study heterogeneity was assessed using the Cochrane Q test and the I2 statistic, while potential publication bias was evaluated through Egger’s regression test and visual inspection of funnel plots. Results: The meta-analysis revealed that daratumumab-containing regimens were associated with a 54.4% reduction in the risk of disease progression or death (hazard ratio[HR] 0.4558; 95% confidence-interval [CI]: 0.4031–0.5154). Similar results were observed using a random-effects model (HR 0.4667; 95% CI: 0.3771–0.5776), despite moderate heterogeneity (I2 = 66.7%). Moreover, patients treated with daratumumab were approximately 2.4 times more likely to achieve a stringent complete response (odds-ratio[OR] 2.38; 95% CI: 1.80–3.15), with moderate heterogeneity across studies (I2 = 58.2%). Conclusions: Incorporating daratumumab into standard therapy for multiple myeloma significantly enhances progression-free survival and the rate of stringent complete response. Despite some heterogeneity, the consistent positive outcomes support its use as an effective treatment option in clinical practice.
- 12 May 2026
- Published by MDPI AG in BioMedInformatics
- Vol. 6 (3) , 28
Open AccessClinical Outcomes of Daratumumab-Containing Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: This study examines the clinical efficacy of daratumumab when combined with other therapeutic agents in patients with multiple myeloma, with a focus on key outcomes including overall response, progression-free survival (PFS), and stringent complete response (sCR). Methods: A systematic literature search was conducted using PubMed, Web of Science, Scopus, and the Cochrane Library. Statistical analyses were performed with R software (version 4.2.2). Between-study heterogeneity was assessed using the Cochrane Q test and the I2 statistic, while potential publication bias was evaluated through Egger’s regression test and visual inspection of funnel plots. Results: The meta-analysis revealed that daratumumab-containing regimens were associated with a 54.4% reduction in the risk of disease progression or death (hazard ratio[HR] 0.4558; 95% confidence-interval [CI]: 0.4031–0.5154). Similar results were observed using a random-effects model (HR 0.4667; 95% CI: 0.3771–0.5776), despite moderate heterogeneity (I2 = 66.7%). Moreover, patients treated with daratumumab were approximately 2.4 times more likely to achieve a stringent complete response (odds-ratio[OR] 2.38; 95% CI: 1.80–3.15), with moderate heterogeneity across studies (I2 = 58.2%). Conclusions: Incorporating daratumumab into standard therapy for multiple myeloma significantly enhances progression-free survival and the rate of stringent complete response. Despite some heterogeneity, the consistent positive outcomes support its use as an effective treatment option in clinical practice.
- Open Access
- 28 September 2025
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
- No. 3(103),p. 65-74
The associations between urinary neutrophil gelatinase-associated lipocalin, ambulatory blood pressure monitoring, echocardiography, and diabetic kidney disease in children
One of the most common microvascular complications of diabetes is diabetic nephropathy, characterized by pathological alterations in the glomeruli leading to albuminuria, hypertension, and progressive loss of renal function. This study aimed to determine whether type 1 diabetic nephropathy was present in children by evaluating urinary Neutrophil gelatinase-associated lipocalin (uNGAL) and ambulatory blood pressure monitoring (ABPM). Materials and methods. A cross-sectional study was conducted from July 2023 to July 2024 and included 57 children with type 1 DM who were subdivided into two groups: Group 1 - 36 children without diabetic kidney disease (non-DKD), and Group 2 - 21 children with DKD. All participants underwent history taking, clinical examination, and laboratory investigations, including CBC, urea, creatinine, HbA1c, albumin/creatinine ratio, NGAL, echocardiography, and ABPM. Results. The mean uNGAL level was significantly higher in Group 2 (10.43±18.71 pg/ml) compared with Group 1 (1.56±1.31 pg/ml) (P=0.006). The mean overall and daytime systolic and diastolic blood pressures were also significantly higher in Group 2 (DKD) compared with Group 1 (non-DKD) (P<0.01), as measured by ABPM. In addition, Group 2 had significantly lower LVESD (P=0.008), indicating left ventricular systolic dysfunction. Conclusion. As NGAL is an early indicator of DKD, our findings highlight its predictive importance. In addition, the significantly higher systolic and diastolic blood pressures, along with left ventricular systolic dysfunction in the DKD group, underscore the importance of ABPM and echocardiography in the assessment and follow-up of children with type 1 DM. The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the institution’s local ethics committee. The informed consent was obtained from patients. The authors declare no conflict of interest.
- 28 September 2025
- Published by Group of Companies Med Expert, LLC in UKRAINIAN JOURNAL OF PERINATOLOGY AND PEDIATRICS
- No. 3(103),p. 65-74
Open AccessThe associations between urinary neutrophil gelatinase-associated lipocalin, ambulatory blood pressure monitoring, echocardiography, and diabetic kidney disease in children
One of the most common microvascular complications of diabetes is diabetic nephropathy, characterized by pathological alterations in the glomeruli leading to albuminuria, hypertension, and progressive loss of renal function. This study aimed to determine whether type 1 diabetic nephropathy was present in children by evaluating urinary Neutrophil gelatinase-associated lipocalin (uNGAL) and ambulatory blood pressure monitoring (ABPM). Materials and methods. A cross-sectional study was conducted from July 2023 to July 2024 and included 57 children with type 1 DM who were subdivided into two groups: Group 1 - 36 children without diabetic kidney disease (non-DKD), and Group 2 - 21 children with DKD. All participants underwent history taking, clinical examination, and laboratory investigations, including CBC, urea, creatinine, HbA1c, albumin/creatinine ratio, NGAL, echocardiography, and ABPM. Results. The mean uNGAL level was significantly higher in Group 2 (10.43±18.71 pg/ml) compared with Group 1 (1.56±1.31 pg/ml) (P=0.006). The mean overall and daytime systolic and diastolic blood pressures were also significantly higher in Group 2 (DKD) compared with Group 1 (non-DKD) (P<0.01), as measured by ABPM. In addition, Group 2 had significantly lower LVESD (P=0.008), indicating left ventricular systolic dysfunction. Conclusion. As NGAL is an early indicator of DKD, our findings highlight its predictive importance. In addition, the significantly higher systolic and diastolic blood pressures, along with left ventricular systolic dysfunction in the DKD group, underscore the importance of ABPM and echocardiography in the assessment and follow-up of children with type 1 DM. The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the institution’s local ethics committee. The informed consent was obtained from patients. The authors declare no conflict of interest.
- 30 September 2024
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 33 (6) , 855-863
Role of soluble adhesion molecules (ICAM-1 and E-selectin) in children with sickle cell disease and their association with disease severity and complications
- 30 September 2024
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 33 (6) , 855-863
Role of soluble adhesion molecules (ICAM-1 and E-selectin) in children with sickle cell disease and their association with disease severity and complications
- 21 November 2022
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 32 (1) , 37-41
Altered expression of NLRP3 inflammasome in pediatric patients with primary immune thrombocytopenia and its relation to disease activity
- 21 November 2022
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 32 (1) , 37-41
Altered expression of NLRP3 inflammasome in pediatric patients with primary immune thrombocytopenia and its relation to disease activity
- 26 March 2022
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 16 (4) , 102473
The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: A case-control study
- 26 March 2022
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 16 (4) , 102473
The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: A case-control study
- Open Access
- 14 November 2021
- Published by Springer Nature in Beni-Suef University Journal of Basic and Applied Sciences
- Vol. 10 (1) , 1-7
Clinical, laboratory, and radiological characteristics of COVID-19-infected children admitted to pediatric intensive care unit: a single-center experience
Background: During the second wave of COVID-19, there is an increasing incidence of reported cases in children compared to the early wave. Data on the clinical and laboratory characteristics of COVID-19 in children are evolving, and reports on the characteristics and outcomes of severe COVID-19 in children are still under evaluation. We aimed to describe the clinical, laboratory, and radiological characteristics and outcomes of children with COVID-19 infection admitted to the pediatric intensive care unit (PICU). Results: The study included 27 children with COVID-19 infection. Fever, respiratory, and gastrointestinal (GIT) symptoms were predominant presenting symptoms in our patients. The median age of our patients was 9 months (2 m–12 years). Comorbidity was reported in 59.3%. The typical laboratory findings were leukocytosis, lymphopenia, elevated C-reactive proteins levels, and elevated d-dimer levels. The most frequent radiological findings were ground-glass opacities in 100% of patients and bilateral findings in 96%, while cardiomegaly was found in 44% of patients. The multisystem inflammatory syndrome was reported in 33% of patients with GIT symptoms were the most frequent presenting symptoms. Myocarditis was reported in 22% of patients. The mortality rate in this cohort was 14.8%. On multivariate analysis, the only predictor of mortality was the development of MIS-C. Conclusions: COVID-19 is more severe in children with comorbid conditions. Fever, respiratory and gastrointestinal (GIT) symptoms were predominant presenting symptoms. MIS-C is of increasing concern in children with high mortality rates.
- 14 November 2021
- Published by Springer Nature in Beni-Suef University Journal of Basic and Applied Sciences
- Vol. 10 (1) , 1-7
Open AccessClinical, laboratory, and radiological characteristics of COVID-19-infected children admitted to pediatric intensive care unit: a single-center experience
Background: During the second wave of COVID-19, there is an increasing incidence of reported cases in children compared to the early wave. Data on the clinical and laboratory characteristics of COVID-19 in children are evolving, and reports on the characteristics and outcomes of severe COVID-19 in children are still under evaluation. We aimed to describe the clinical, laboratory, and radiological characteristics and outcomes of children with COVID-19 infection admitted to the pediatric intensive care unit (PICU). Results: The study included 27 children with COVID-19 infection. Fever, respiratory, and gastrointestinal (GIT) symptoms were predominant presenting symptoms in our patients. The median age of our patients was 9 months (2 m–12 years). Comorbidity was reported in 59.3%. The typical laboratory findings were leukocytosis, lymphopenia, elevated C-reactive proteins levels, and elevated d-dimer levels. The most frequent radiological findings were ground-glass opacities in 100% of patients and bilateral findings in 96%, while cardiomegaly was found in 44% of patients. The multisystem inflammatory syndrome was reported in 33% of patients with GIT symptoms were the most frequent presenting symptoms. Myocarditis was reported in 22% of patients. The mortality rate in this cohort was 14.8%. On multivariate analysis, the only predictor of mortality was the development of MIS-C. Conclusions: COVID-19 is more severe in children with comorbid conditions. Fever, respiratory and gastrointestinal (GIT) symptoms were predominant presenting symptoms. MIS-C is of increasing concern in children with high mortality rates.
- 23 March 2020
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 29 (3) , 639-643
Diagnostic value of CD64 in early detection of neonatal sepsis
- 23 March 2020
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 29 (3) , 639-643
Diagnostic value of CD64 in early detection of neonatal sepsis